Inventor · disambiguated record
Thor Grundtvig Theander
Also filed as: THEANDER THOR · THEANDER THOR GRUNDTVIG
10 granted patents·2 pending applications·62 citations·filing 1993–2022
86Inventor score
Files withUNIV COPENHAGEN5VAR2 PHARMACEUTICALS APS3KOBENHAVNS UNI PANIUM1LICA PHARMACEUTICALS AS1STATENS SERUMINSTITUT1
Top patents by PatentIndex Score
12 records- 0189US5985935ATreatment and prophylaxis of diseases caused by parasites, or bacteriaSTATENS SERUMINSTITUT·Filed 1993·Granted Nov 16, 1999·49 cites·47 claims
- 0280US11497800B2Virus-like particle with efficient epitope displayUNIV COPENHAGEN·Filed 2019·Granted Nov 15, 2022·1 cites·20 claims
- 0380US10086056B2Virus-like particle with efficient epitope displayUNIV COPENHAGEN·Filed 2017·Granted Oct 2, 2018·2 cites·20 claims
- 0479US10526376B2Virus-like particle with efficient epitope displayUNIV COPENHAGEN·Filed 2016·Granted Jan 7, 2020·2 cites·20 claims
- 0573US2023078675A1Virus-like particle with efficient epitope displayUNIV COPENHAGEN·Filed 2022·Application pending·0 cites
- 0669US9926350B2Targeting of chondroitin sulfate glycansVAR2 PHARMACEUTICALS APS·Filed 2016·Granted Mar 27, 2018·1 cites·10 claims
- 0759US7745580B2Compounds useful in the diagnosis and treatment of pregnancy-associated malariaUINV KOBENHAVNS·Filed 2003·Granted Jun 29, 2010·5 cites·7 claims
- 0855US11787844B2Targeting of chondroitin sulfate glycansVAR2 PHARMACEUTICALS APS·Filed 2013·Granted Oct 17, 2023·0 cites·13 claims
- 0952US9932375B2Targeting of chondroitin sulfate glycansVAR2 PHARMACEUTICALS APS·Filed 2016·Granted Apr 3, 2018·0 cites·7 claims
- 1044US2009324628A1Compounds useful in the diagnosis and treatment of malariaKOBENHAVNS UNI PANIUM·Filed 2004·Application pending·0 cites
- 1140US11129882B2Virus like particle with efficient epitope displayUNIV COPENHAGEN·Filed 2016·Granted Sep 28, 2021·0 cites·15 claims
- 1228US6603046B1Bis-aromatic a,β-unsaturated ketonesLICA PHARMACEUTICALS AS·Filed 1998·Granted Aug 5, 2003·2 cites·22 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →